Antineutrophil Cytoplasmic Antibody -associated Nephritis
📧 Sign up to get email alerts when something new happens for Antineutrophil Cytoplasmic Antibody -associated Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN) [Phase 1, Phase 2]
Telitacicept is being studied for ANCA-associated nephritis in Phase 1/Phase 2 trials, with the study currently active but not recruiting.